Results 11 to 20 of about 9,389 (214)

The 245 kb amplified chromosome of Leishmania (V.) braziliensis contains a biopterin transporter gene [PDF]

Memorias do Instituto Oswaldo Cruz, 2003
Leishmania (V.) braziliensis M2903 presents a small linear and stable 245 kb chromosome originating from a genomic amplification. Similar amplifications present in other species of Leishmania contain a gene coding for a biopterin transporter.
MCR Sampaio, YM Traub-Cseko
doaj   +4 more sources

Development of Colombian isolates of Leishmania (Viannia) panamensis, Le. (V.) guyanensis and Le. (V.) braziliensis in the sandfly Lutzomyia intermedia (Lutz & Neiva, 1912) under experimental conditions [PDF]

Memorias do Instituto Oswaldo Cruz, 1993
The development of Colombian Leishmania species of the subgenus Viannia in Lutzomyia intermedia was similar to that observed with Brazilian Le. (V.) braziliensis: colonization of the pylorus by paramastigotes; promastigotes in the midgut and massive ...
Elizabeth Ferreira Rangel, Bruno L. Travi, André F. Barbosa, James Montoya   +3 more
doaj   +4 more sources

Leishmania V. braziliensis infection in asymptomatic domestic animals within an endemic region in the Northeast of Brazil. [PDF]

Rev Soc Bras Med Trop, 2022
American cutaneous leishmaniasis is a commonly neglected, vector-borne tropical parasitic disease that is a major public health concern in Brazil. Leishmania (Viannia) braziliensis is the main species associated with the disease. Accurate diagnosis is based on epidemiological surveillance, clinical assessment, and laboratory testing.
Silva CJD, Lima KPB, Monteiro JFDCLS, Silva AKSFD, Silva FJD, Pereira AMS, Hernandes VP, Silva EDD, Silva CSAGE, Brandão Filho SP, Brito MEF.   +10 more
europepmc   +5 more sources

Parasite Killing of Leishmania (V) braziliensis by Standardized Propolis Extracts. [PDF]

Evid Based Complement Alternat Med, 2017
Treatments based on antimonials to cutaneous leishmaniasis (CL) entail a range of toxic side effects. Propolis, a natural compound widely used in traditional medical applications, exhibits a range of biological effects, including activity against infectious agents.
Rebouças-Silva J, Celes FS, Lima JB, Barud HS, de Oliveira CI, Berretta AA, Borges VM.   +6 more
europepmc   +5 more sources

Analysis of the IGS rRNA Region and Applicability for Leishmania (V.) braziliensis Characterization. [PDF]

J Parasitol Res, 2020
The causative species is an important factor influencing the evolution of American cutaneous leishmaniasis (ACL). Due to its wide distribution in endemic areas, Leishmania (V.) braziliensis is considered one of the most important species in circulation in Brazil.
de Goes TC, de Morais RCS, de Melo MGN, E Silva RP, Rezende AM, de Paiva-Cavalcanti M.   +5 more
europepmc   +4 more sources

Molecular Detection of <i>Leishmania</i> (<i>V.</i>) <i>braziliensis</i> and <i>Leishmania</i> (<i>M.</i>) <i>martiniquensis</i> Infecting Domestic Animals from Panama, Central America. [PDF]

Animals (Basel)
Cutaneous leishmaniasis (CL) is a vector-borne zoonotic disease affecting the skin and mucous membranes of animals and humans. While CL is commonly diagnosed and studied in humans in Panama, limited information exists on its occurrence in domestic animals and their potential role as reservoirs.
Pineda V, Calzada JE, Montilla S, Rodríguez I, Howard E, Torres AI, Vasquez V, Reina A, Saldaña A, González K.   +9 more
europepmc   +3 more sources

The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice. [PDF]

Front Immunol, 2019
Leishmania (V.) braziliensis is the etiological agent of Cutaneous (CL) and Mucocutaneous leishmaniasis (ML) in the New World. CL can be more benign but ML can be severe and disfiguring. Immunity to these diseases include hypersensitivity, an enhanced inflammatory response with strong IFN-γ and TNF-α secretion.
Alves-Silva MV, Nico D, de Luca PM, Palatnik de-Sousa CB.   +3 more
europepmc   +5 more sources

Genomic characterization of Leishmania (V.) braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin B. [PDF]

Sci Rep
Leishmaniasis, a vector-borne disease caused by protozoa from the Leishmania genus, presents a wide range of clinical manifestations in humans and varying responses to treatments. The main clinical presentations correspond with visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucosal leishmaniasis (ML).
Gonzalez-Garcia LN, Rodríguez-Guzmán AM, Vargas-León CM, Aponte S, Bonilla-Valbuena LA, Matiz-González JM, Clavijo-Vanegas AM, Duarte-Olaya GA, Aguilar-Buitrago C, Urrea DA, Duitama J, Echeverry MC.   +11 more
europepmc   +4 more sources

Simultaneous Infection with Leishmania (Viannia) braziliensis and L. (V.) lainsoni in a Peruvian Patient with Cutaneous Leishmaniasis [PDF]

The American Society of Tropical Medicine and Hygiene, 2013
Conventional understanding suggests that simultaneous infection with more than one species of Leishmania is unlikely. In Peru, co-infections are clinically relevant because causative species dictates prognosis, treatment response, and follow-up. We describe a case of Leishmania (Viannia) braziliensis and L.
Veland, Nicolas, Valencia, Braulio Mark, Alba, Milena, Adaui, Vanessa, Llanos Cuentas, Elmer Alejandro, Arévalo Zelada, Jorge Luis, Boggild, Andrea K.   +6 more
openaire   +3 more sources

The spiny rat Proechimys guyannensis (Rodentia: Echimydae) fails to respond to intradermal inoculation with Leishmania (Viannia) braziliensis [PDF]

Acta Amazonica, 2015
Leishmaniasis a disease of worldwide occurrence is caused by protozoa of the Leishmania genus. In Brazil, Leishmania (Viannia) braziliensis is the main parasite responsible for the American cutaneous leishmaniasis.
Stela Rechinelli PASSOS, Ana Paula MADUREIRA, Sayanne Luns Hatum de ALMEIDA, Marcos Santos ZANINI   +3 more
doaj   +2 more sources